1.
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases
by Stolt, P
Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.835-841

2.
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ES...
by Combe, B
Annals of the rheumatic diseases, 2007-01, Vol.66 (1), p.34-45

3.
SP0125 Co-morbidity in rheumatic diseases
by Klareskog, L
Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.31-31

4.
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis
by Padyukov, Leonid
Annals of the rheumatic diseases, 2011-02, Vol.70 (2), p.259-265

5.
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
by Askling, J
Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1421-1426

6.
Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study
by Keystone, E C
Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.789-796

7.
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
by Askling, J
Annals of the rheumatic diseases, 2005-10, Vol.64 (10), p.1414-1420

8.
Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile
by Lundberg, Karin
Annals of the Rheumatic Diseases, 2013-05, Vol.72 (5), p.652-658

9.
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity an...
by Rönnelid, J
Annals of the rheumatic diseases, 2005-12, Vol.64 (12), p.1744-1749

10.
Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case–control studies
by Källberg, H
Annals of the rheumatic diseases, 2009-02, Vol.68 (2), p.222-227

11.
Citrullination is an inflammation-dependent process
by Makrygiannakis, D
Annals of the rheumatic diseases, 2006-09, Vol.65 (9), p.1219-1222

12.
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells
by Makrygiannakis, D
Annals of the rheumatic diseases, 2008-10, Vol.67 (10), p.1488-1492

13.
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
by Askling, J
Annals of the Rheumatic Diseases, 2009-05, Vol.68 (5), p.648-653

14.
Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study
by Bengtsson, C
Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1588-1594

15.
Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies
by Jiang, Xia
Annals of the rheumatic diseases, 2014-10, Vol.73 (10), p.1761-1768

16.
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial
by van der Heijde, D
Annals of the rheumatic diseases, 2008-09, Vol.67 (9), p.1267-1270

17.
Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles
by Snir, O
Annals of the rheumatic diseases, 2009-05, Vol.68 (5), p.736-743

18.
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled tr...
by Klareskog, Lars
The Lancet (British edition), 2004, Vol.363 (9410), p.675-681

19.
Swedish registers to examine drug safety and clinical issues in RA
by Askling, J
Annals of the Rheumatic Diseases, 2006-06, Vol.65 (6), p.707-712

20.
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study
by Stolt, P
Annals of the rheumatic diseases, 2005-04, Vol.64 (4), p.582-586
